Padsevonil

Padsevonil is under investigation in clinical trial NCT03695094 (A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil). The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include padsevonilum, (4R)-4-(2-chloro-2, 2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2, 1-b][1, 3 and 4]thiadiazol-5-yl]methyl]pyrrolidin-2-one. Its PubChem CID is 52911611.

CAS No 1294000-61-5
Molecular Formula C14H14ClF5N4O2S
Molecular Weight 432.8 g/mol
Synonyms (4R)-4-(2-chloro-2,2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl]pyrrolidin-2-one

Frequently Asked Questions